News
Halliburton's Asset Sale Halt Paves Way for Venezuela Restart
Halliburton Company’s HAL auction of equipment has been called off by Venezuela after intervention from the U.S. administration. The decision comes as Washington works to facilitate the return of
DICK'S Sporting's Digital Strategy & Other Efforts Bolster Growth
DICK'S Sporting Goods, Inc.’s DKS digital strategy is a key growth catalyst, underscoring its rapid evolution into a leading omnichannel sports retailer. Its expanding digital capabilities are
Merck's Keytruda Drives its 2025 Revenue Surge: What's Ahead?
Merck MRK has a strong foothold in the oncology market, primarily supported by its biggest revenue driver, Keytruda. The blockbuster PD-1 inhibitor accounts for around 55% of the company’s
Earnings Preview: Kohl's (KSS) Q4 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when Kohl's (KSS) reports results for the quarter ended January 2026. While this widely-known consensus outlook is
Best Momentum Stock to Buy for March 3rd
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 3rd:
Sibanye Gold Limited SBSW: This precious metal mining company, with a diverse
Zacks Initiates Coverage of Good Times Restaurants With Neutral Recommendation
Zacks Investment Research has recently initiated coverage of Good Times Restaurants Inc. GTIM, assigning a "Neutral" recommendation to the company's shares. This assessment comes amid a mixed
Arthur J. Gallagher Banks on Solid Segmental Growth Amid Cost Woes
Arthur J. Gallagher & Co. AJG continues to benefit from solid retention, improving renewal premiums and organic and inorganic growth.AJG remains focused on generating both organic (particularly
Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan
Sanofi SNY announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation to Waylirz (rilzabrutinib) for the treatment of IgG4-related disease (IgG4-RD)
3 Reasons Why Mining ETFs Are Shining Bright
Metal and mining stocks are shining bright this year, withState Street SPDR S&P Metals & Mining ETF XME gaining 11% so far this year (as of Feb. 27, 2026), clearly outperforming State Street SPDR
Target Beats Q4 Earnings Estimates, Eyes Sales Growth in FY2026
Target Corporation TGT reported fourth-quarter fiscal 2025 results, wherein the top line fell short of the Zacks Consensus Estimate, while the bottom line surpassed the same. The company continued
Wall Street Analysts Predict a 124.49% Upside in Senseonics (SENS): Here's What You Should Know
Senseonics Holdings (SENS) closed the last trading session at $8.33, gaining 14.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Believe Trimble (TRMB) Could Rally 33.68%: Here's is How to Trade
Shares of Trimble Navigation (TRMB) have gained 0.8% over the past four weeks to close the last trading session at $68.41, but there could still be a solid upside left in the stock if short-term
Does Replimune Group (REPL) Have the Potential to Rally 79.61% as Wall Street Analysts Expect?
Shares of Replimune Group, Inc. (REPL) have gained 2.7% over the past four weeks to close the last trading session at $7.16, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade
Prothena (PRTA) closed the last trading session at $9.4, gaining 5.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts See a 32.67% Upside in OrthoPediatrics (KIDS): Can the Stock Really Move This High?
OrthoPediatrics (KIDS) closed the last trading session at $19.22, gaining 11.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Should You Buy Central Garden (CENT) After Golden Cross?
From a technical perspective, Central Garden & Pet Company (CENT) is looking like an interesting pick, as it just reached a key level of support. CENT's 50-day simple moving average crossed above
Wall Street Analysts See a 28.36% Upside in On Holding (ONON): Can the Stock Really Move This High?
Shares of On Holding (ONON) have gained 1.8% over the past four weeks to close the last trading session at $46.76, but there could still be a solid upside left in the stock if short-term price
After Golden Cross, Global Industrial (GIC)'s Technical Outlook is Bright
From a technical perspective, Global Industrial Company (GIC) is looking like an interesting pick, as it just reached a key level of support. GIC's 50-day simple moving average crossed above its
Does PROG Holdings (PRG) Have the Potential to Rally 30.24% as Wall Street Analysts Expect?
Shares of PROG Holdings (PRG) have gained 0.9% over the past four weeks to close the last trading session at $33.56, but there could still be a solid upside left in the stock if short-term price
Shinhan Financial (SHG) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
A downtrend has been apparent in Shinhan Financial (SHG) lately. While the stock has lost 6.3% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last
Wall Street Analysts Think Biodesix (BDSX) Could Surge 111.62%: Read This Before Placing a Bet
Shares of Biodesix, Inc. (BDSX) have gained 53.1% over the past four weeks to close the last trading session at $15.75, but there could still be a solid upside left in the stock if short-term price
After Golden Cross, Central Garden (CENTA)'s Technical Outlook is Bright
Central Garden & Pet Company (CENTA) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, CENTA's 50-day simple moving average
DBS Group (DBSDY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
A downtrend has been apparent in DBS Group Holdings Ltd (DBSDY) lately. While the stock has lost 5.5% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed
Here's Why TriMas (TRS) is a Strong Momentum Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research


